![SAR Televenture raises ₹450 cr in largest-ever public offer on SME platform](https://images.assettype.com/fortuneindia%2F2023-04%2F3dcc3c86-73f4-4b15-9551-aceeaec04b8b%2Fstock.jpg?rect=0,233,2121,1061&w=300&q=95)
SAR Televenture raises ₹450 cr in largest-ever public offer on SME platform
The composite public issue of ₹450 cr was a combination of the highest-ever rights issue of ₹300 cr and the second-largest FPO of ₹150 cr in the SME space.
The composite public issue of ₹450 cr was a combination of the highest-ever rights issue of ₹300 cr and the second-largest FPO of ₹150 cr in the SME space.
The IPO of Akums Drugs and Pharmaceuticals is a combination of fresh equities worth ₹680 crore and OFS of 1.73 crore shares worth ₹1,177 crore.
The food tech company has cumulatively enabled over ₹1,000 crore of ESOPs liquidity over the five events, benefitting over 3,200 employees.
All these four companies filed their DRHP with the SEBI in February this year, while observations came between June 29 and July 2, 2024.
Bank working to diversify from gold and become a pan-India player with a larger share of customer wallet.
CSB Bank tops the list of banks adding credibility to India’s financial system by adopting best corporate governance practices.
The IPO of the trucking platform is a mix of fresh equity shares worth ₹550 crore and an OFS of up to 2.16 crore shares.
The IPO is a mix of fresh issue of equity shares up to ₹2,000 crore and an offer for sale (OFS) of up to ₹1,000 crore by ACME Cleantech Solutions.
Ahead of opening of their IPOs, Emcure Pharma raised ₹582.6 cr via anchor book, while Bansal Wire garnered ₹223.5 cr through anchor investors.
The public issue of Allied Blenders & Distillers was subscribed 23.55 times, with QIBs quota subscribing the highest 50.37 times